Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Effects of magnesium sulfate on blood clotting after laparoscopic gynecological surgeries

Official title: Effect of Magnesium Sulfate on Postoperative Hypercoagulability Using Thromboelastometry in Laparoscopic Gynecological Surgeries

Run by Aretaieion University Hospital · NCT06717490 · Data updated 2026-11-12

This study is testing if giving magnesium sulfate after laparoscopic gynecological surgeries can help reduce the risk of blood clots in patients.

More Magnesium Sulfate trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorAretaieion University Hospital
Academic / other
Locations1 site (Athens, Attica)
StatusRecruiting
StartedDecember 2024
Main results expectedNovember 2025
Study endsNovember 2025
Registry record updatedDecember 5, 2024
Trial IDNCT06717490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include ASA I and II patients over 18 years old undergoing laparoscopic gynecological surgeries who are receiving prophylactic anticoagulant therapy.

Probably not a fit

Patients with ASA classification III or higher, those under 18 years old, or those with significant comorbidities such as severe anemia or known hematologic disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized, double-blind study investigates how magnesium sulfate affects postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia. Participants are randomly assigned to receive either magnesium sulfate or a placebo (normal saline), with both patients and investigators unaware of the treatment allocation. The study utilizes thromboelastometry to measure various blood coagulation parameters, including clotting time and coagulation markers, to determine the therapeutic potential of magnesium sulfate in reducing hypercoagulability after surgery.

Why it matters

Potential benefit: If successful, this study could lead to improved management of postoperative blood clotting, reducing the risk of complications for patients undergoing laparoscopic gynecological surgeries.

How similar studies have gone: While the specific application of magnesium sulfate in this context may be novel, similar studies investigating anticoagulant therapies have shown promising results in managing postoperative hypercoagulability.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ASA I and II patients
* Laparoscopic gynecological surgeries
* age \>18 years
* Patients receiving prophylactic anticoagulant therapy 12 hours before surgery based on the Caprini score
* Patients receiving prophylactic anticoagulant therapy 12 hours postoperatively based on the Caprini score.

Exclusion Criteria:

* ASA ≥ III
* age \<18 years
* BMI \>40 kg/m²
* Pregnancy
* Known hematologic disorders
* Liver/kidney/cardiovascular disease
* Severe anemia (6,5- 7,9 g/dl)
* Inability or refusal to provide informed consent

Where it's running

  • Aretaieion University Hospital
    Athens, Attica, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.